Traws Pharma stock soars after completing COVID-19 treatment study

Investing.com - Gold prices surged to an unprecedented high above $5,100 per ounce on Monday, as escalating geopolitical tensions drove investors toward safe-haven assets.

The precious metal has gained 18% since the beginning of 2026, extending its multi-year rally amid persistent global uncertainties and inflation concerns that have enhanced its appeal as a store of value.

Spot gold reached the milestone during Monday’s trading session, continuing its upward trajectory that market observers attribute to ongoing conflicts in multiple regions and economic sanctions that have disrupted traditional investment channels.

Silver prices also benefited from the safe-haven rush, with spot silver climbing to a record peak of $112.18 per ounce, reflecting the broader momentum in precious metals markets.

Trading volumes remained robust throughout the session as institutional investors increased their precious metals allocations, according to market data showing substantial inflows into gold-backed exchange-traded funds and physical bullion purchases.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- NetSol Technologies Inc (NASDAQ:NTWK) stock gained 2.1% Monday after the company announced the appointment of Sardar Abubakr as its new Chief Financial Officer, effective January 20, 2026.

Abubakr, who will be based in Dubai, brings over 20 years of international leadership experience across Europe and Asia. He most recently served as Vice President of New Business Ventures and M&A at Jazz, a VEON Group subsidiary, where he led venture creation, strategic transactions, and restructuring initiatives.

The current CFO, Roger K. Almond, will remain with the company as Chief Accounting Officer, maintaining responsibility for global accounting operations and SEC filings. This transition aims to provide continuity while the company pursues its growth strategy.

"We are excited to welcome Mr. Abubakr to NETSOL at a pivotal moment in our growth," said Naeem Ghauri, President and Co-Founder of NETSOL Technologies. "Sardar brings deep international leadership experience across finance, strategy and transformation, with a proven track record operating in complex, multi-entity environments at large, publicly traded organizations."

Abubakr’s experience includes senior leadership roles in telecommunications, fintech, and digital organizations. His contributions to digital acceleration have been recognized with a Global Innovation Award from the ITU (United Nations). He is a Fellow of the Association of Chartered Certified Accountants (FCCA).

NetSol Technologies provides AI-enabled solutions for OEMs, dealerships, and financial institutions to sell, finance, and lease assets.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- Arbe Robotics Ltd (NASDAQ:ARBE) stock plunged 17.4% Monday after the perception radar solutions company announced it has priced an underwritten offering of 11.5 million ordinary shares at $1.40 per share.

The Israel-based company expects to raise approximately $16.1 million in gross proceeds from the offering before deducting underwriting discounts, commissions, and other expenses. Arbe has also granted underwriters a 30-day option to purchase up to an additional 1.725 million ordinary shares at the same price.

The significant share dilution appears to be driving the stock’s decline as the offering price of $1.40 represents a substantial discount to recent trading levels. The company stated it intends to use the net proceeds for working capital and general corporate purposes.

Canaccord Genuity is serving as the sole bookrunner for the offering, while Roth Capital Partners and WestPark Capital are acting as co-managers. The offering is expected to close around January 27, 2025, subject to customary closing conditions.

Arbe Robotics, which trades on both NASDAQ and the Tel Aviv Stock Exchange (TASE:ARBE), specializes in perception radar solutions for advanced driver assistance systems and autonomous vehicles.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- Cogent Biosciences Inc (NASDAQ:COGT) stock rose 3.4% Monday after the company announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for its bezuclastinib treatment in combination with sunitinib for patients with Gastrointestinal Stromal Tumors who have received prior treatment with imatinib.

The designation, which is intended to expedite the review process for medicines that show potential for substantial improvement over available therapies, was based on results from the company’s PEAK trial. The study demonstrated that the bezuclastinib combination reduced the risk of disease progression or death by 50% compared to the current standard of care.

"We are excited to announce this Breakthrough Therapy Designation which recognizes the potential for the bezuclastinib combination to substantially improve upon the currently available treatment options for patients with imatinib-resistant GIST," said Andrew Robbins, Cogent’s President and Chief Executive Officer.

The FDA previously agreed to accept Cogent’s New Drug Application (NDA) under the Real-Time Oncology Review program, which allows for pre-submission of components to expedite the review process. The company remains on track to complete its NDA submission in April 2026.

Median progression-free survival in the PEAK trial was 16.5 months for the bezuclastinib combination versus 9.2 months for sunitinib monotherapy. The company plans to present full results from the trial at a major medical meeting during the first half of 2026.

Cogent also expects to initiate a Phase 2 trial in mid-2026 investigating the treatment combination for first-line GIST patients with exon 9 mutations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- Ascent Solar Technologies Inc (NASDAQ:ASTI) stock tumbled 20.4% on Monday after the company announced a private placement offering expected to raise approximately $10 million.

The thin-film solar panel manufacturer entered into definitive agreements to sell 1,818,182 shares of common stock (or pre-funded warrants) along with accompanying warrants at $5.50 per share. The offering, priced at-the-market under Nasdaq rules, includes series A warrants and short-term series B warrants that could potentially bring in an additional $15 million if fully exercised.

H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering, which is expected to close around January 26, 2026, subject to customary closing conditions.

Ascent Solar indicated it plans to use the net proceeds for general working capital needs. The securities being offered have not been registered under the Securities Act of 1933 and cannot be sold in the United States without effective registration or an applicable exemption.

As part of the agreement, the company has committed to filing registration statements with the SEC covering the resale of the shares and has agreed to certain restrictions on issuing additional shares for 30 days after the registration statement becomes effective, with limited exceptions.

Ascent Solar Technologies specializes in flexible thin-film solar panels designed for space, military, defense, and other applications where mass, performance, reliability, and resilience are critical factors.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- The CEO of aircraft leasing giant SMBC Aviation has publicly called on Airbus (EPA:AIR) and other manufacturers to resolve persistent supply chain problems and meet delivery deadlines.

Speaking at the Airline Economics conference on Monday, Peter Barrett emphasized the need for predictability in aircraft deliveries after six years of disruptions.

"I think delivery: I’ve said this to him privately and I’m happy to say it publicly," Barrett told Reuters, referring to the new head of Airbus’ jet division who made his debut appearance at the conference. "We all understand the challenges that COVID brought, but ultimately people need a degree of predictability and certainty."

Barrett acknowledged that both Airbus and Boeing are making progress but stated they are "not where they need to be." He extended this assessment to engine manufacturers as well.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.